Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
03737 ZHONGZHIPHARM
RTNominal down1.040 -0.020 (-1.887%)
Others

30/06/2021 15:31

Zhongzhi Pharm (03737) to raise HK$36.11 million

[ET Net News Agency, 30 June 2021] Zhongzhi Pharmaceutical Holdings Limited (03737)
said Novich has conditionally agreed to subscribe for and the company has conditionally
agreed to allot and issue a total of 23.6 million subscription shares at the subscription
price which shall be satisfied by payment of HK$36.11 million in cash. The net proceeds
are estimated to be approximately HK$36.06 million. As a result, the net price per share
will be approximately HK$1.53.
The company intends to use the net proceeds to enhance the distribution network, the
public awareness of the brand and for shareholders' dividend. (RC)

Remark: Real time quote last updated: 03/12/2021 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2021 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.